Study: CBD in low doses shows efficacy against Parkinson’s Disease

Scientists study the effects of Epidiolex drug against Parkinson's


A group of scientists tested the effectiveness and tolerance of cannabidiol (CBD)-based drug Epidiolex against Parkinson’s at low doses.

Researchers realized that low doses are effective in reducing symptoms related to this disease. However, high doses were associated with elevations of liver enzymes.

The study was conducted by the Department of Neurology at the Colorado School.

“CBD, in the form of Epidiolex, may be effective in PD, but the relatively high dose used in this study was associated with elevations of liver enzymes. Randomized controlled trials are needed to investigate various forms of cannabis in PD. “

Read the full investigation:





3 tips for using medical cannabis in pets

April 28, 2023

Mientras que unos pocos celebran muchos otros sufren

April 22, 2023

THC-free cannabis flowers are now legally sold in Costa Rica

March 16, 2023